Application Nr Approved Date Route Status External Links
BLA125249 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Arcalyst ® (Rilonacept) Is An Interleukin-1 Blocker Indicated For The Treatment Of Cryopyrin-Associated Periodic Syndromes (Caps), Including Familial Cold Auto-Inflammatory Syndrome (Fcas) And Muckle-Wells Syndrome (Mws) In Adults And Children 12 And Older. Arcalyst (Rilonacept) Is An Interleukin-1 Blocker Indicated For The Treatment Of Cryopyrin-Associated Periodic Syndromes (Caps), Including Familial Cold Auto-Inflammatory Syndrome (Fcas) And Muckle-Wells Syndrome (Mws) In Adults And Children 12 And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rilonacept

Comments